What should you know about Roche next-generation sequencing?

The laboratory extracts DNA, or sometimes RNA, from blood, saliva, another body sample or tumour tissue. The test reads selected stretches of genetic material and compares the sequence with a reference. A report may identify a variant, show that no relevant variant was detected, or state that a finding needs further interpretation.

The purpose depends on the sample and the question. Testing can look for inherited variants relevant to family health, changes in a tumour that may help treatment planning, or genetic differences used in reproductive screening. A finding does not automatically prove that a person will develop cancer or that a particular medicine will work. Results need interpretation by a clinician or genetics professional.

Before testing, ask what sample is needed, which genes or regions are included and how results may affect you or relatives. Tell the team about personal and family history. Afterward, ask whether a variant is inherited, tumour-specific, uncertain or actionable, and whether confirmatory testing is needed.

Arrange timely follow-up if the report identifies a potentially important variant, recommends family testing or changes a planned treatment discussion. Seek urgent medical help for severe symptoms such as breathing difficulty, chest pain or sudden weakness; a sequencing report cannot assess an acute emergency.

What was this test designed to answer? Is the finding inherited or limited to the tumour? Does it change diagnosis, monitoring or treatment options? Should relatives consider genetic counselling or testing?